JPS6046083B2 - cosmetics - Google Patents
cosmeticsInfo
- Publication number
- JPS6046083B2 JPS6046083B2 JP57063599A JP6359982A JPS6046083B2 JP S6046083 B2 JPS6046083 B2 JP S6046083B2 JP 57063599 A JP57063599 A JP 57063599A JP 6359982 A JP6359982 A JP 6359982A JP S6046083 B2 JPS6046083 B2 JP S6046083B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- vitamin
- weight
- astringent
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000002537 cosmetic Substances 0.000 title claims description 23
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 44
- 229960005070 ascorbic acid Drugs 0.000 claims description 22
- 239000002211 L-ascorbic acid Substances 0.000 claims description 15
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 14
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 229940088594 vitamin Drugs 0.000 description 15
- 229930003231 vitamin Natural products 0.000 description 15
- 235000013343 vitamin Nutrition 0.000 description 15
- 239000011782 vitamin Substances 0.000 description 15
- 150000003722 vitamin derivatives Chemical class 0.000 description 15
- 239000006210 lotion Substances 0.000 description 14
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000011668 ascorbic acid Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 235000010323 ascorbic acid Nutrition 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- 238000005342 ion exchange Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 244000025254 Cannabis sativa Species 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 102000009027 Albumins Human genes 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- 238000004040 coloring Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000005562 fading Methods 0.000 description 4
- 229940041616 menthol Drugs 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000003212 astringent agent Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 235000015961 tonic Nutrition 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 241000208690 Hamamelis Species 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- -1 chlorohydroxyaluminum Chemical compound 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- 230000004845 protein aggregation Effects 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 150000003697 vitamin B6 derivatives Chemical class 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 244000141009 Hypericum perforatum Species 0.000 description 1
- VAYOSLLFUXYJDT-RDTXWAMCSA-N Lysergic acid diethylamide Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N(CC)CC)C2)=C3C2=CNC3=C1 VAYOSLLFUXYJDT-RDTXWAMCSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000020721 horse chestnut extract Nutrition 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229940045641 monobasic sodium phosphate Drugs 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000006100 radiation absorber Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/002—Aftershave preparations
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Description
【発明の詳細な説明】
本発明は、オドリコ草抽出物とビタミン桟塩酸塩及び
/又はL−アスコルビン酸を配合したことを特長とする
化粧料、とくに皮膚収れん化粧料に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a cosmetic composition, in particular a skin astringent cosmetic composition, which is characterized by blending an extract of staghorn grass with vitamin C. hydrochloride and/or L-ascorbic acid.
従来から、化粧品に皮膚収れん効果を付与するための
手段としては次のようなものがある。5エタノール、イ
ソプロピルアルコールなどの蒸発熱によつて皮膚表面温
度を低下させる現象を利用する物理的なもの。Conventionally, the following methods have been used to impart a skin astringent effect to cosmetics. 5 A physical product that uses the phenomenon of lowering the skin surface temperature due to the heat of evaporation of ethanol, isopropyl alcohol, etc.
5皮膚表面の蛋白質官能基と結びつくような陽イオン性
(例えば塩化アルミニウム、塩基性アルミニウム、クロ
ルヒドロキシアルミニウム等)、あるいは陰イオン性(
例えばクエン酸、酒石酸等の有機酸)の収れん剤を配合
し、皮膚をひきしめるもの。5. Cationic (e.g. aluminum chloride, basic aluminum, chlorohydroxyaluminum, etc.) or anionic (aluminum chloride, etc.) that binds to protein functional groups on the skin surface.
Contains an astringent (for example, organic acids such as citric acid and tartaric acid) to tighten the skin.
6タンニン系化合物を含むハマメリス抽出物、オトギリ
草抽出物、マロニエ抽出物等を配合するもの。Contains Hamamelis extract, Hypericum perforatum extract, horse chestnut extract, etc. containing 6 tannin compounds.
ガンファー、メントール等により末梢神経を刺激し、
効果を官能的に感じさせるもの。 しれル、これらの収
れん剤のうちち、5については少量では余り効果がない
反面、多量に用いると一過性ながら刺激が強く、しかも
収れん効果に持続性が少ない。Stimulating peripheral nerves with gunfer, menthol, etc.
Something that makes the effect feel sensual. Among these astringents, 5 is not very effective when used in small amounts, but when used in large amounts, it causes temporary but strong irritation, and the astringent effect is short-lasting.
5の陽イオン性収れん剤については皮膚安全性面から配
合量を極力抑えねばならず、十分な効果が期待できない
。The amount of the cationic astringent (5) must be kept as low as possible from the viewpoint of skin safety, and sufficient effects cannot be expected.
又、陰イオン型収れん剤は皮膚のPH域に比べてかなり
酸性であるため、pH調整剤、緩衝剤を併用配合するこ
とが一般的に行なわれており、収れん効果は十分満足の
いくものではない。さらに6のハマメリス抽出物等に含
まれるタンニン系の化合物を有効成分として利用する場
合は、光、温度に対して不安定なことが多い上に、鉄イ
オン等の混入によつて著るしい着色が起る場合があり、
効果を十分発揮できるほど多量に配合することができな
い。 については感触的なものであるといえる。 一方
、オドリコ草抽出物はフレグランス・ジャーナル酉、1
01〜105(1978)に記載されているように収れ
ん、血官収縮等の効果があり、ヘアトニツク、化粧水等
の化粧料全般に用いられることは公知である。Furthermore, since anionic astringents are considerably more acidic than the pH range of the skin, it is common practice to combine them with pH adjusters and buffers, but the astringent effect is not fully satisfactory. do not have. Furthermore, when using tannin-based compounds contained in Hamamelis extract, etc., as an active ingredient, they are often unstable to light and temperature, and may cause significant discoloration due to contamination with iron ions, etc. may occur,
It cannot be blended in a large enough amount to achieve sufficient effects. It can be said that it is a matter of feeling. On the other hand, Odoricum extract is used in Fragrance Journal Rooster, 1
01-105 (1978), it is known that it has effects such as astringency and blood contraction, and is used in general cosmetics such as hair tonics and lotions.
又、欧州では中世から婦人科疾患、柱痰剤として煎じて
使われている。 しかしながら、オドリコ草抽出物を単
独で化粧料に配合する場合には、その収れん効果は小さ
く、ある程度の収れん効果を得ようとするときでさえも
、多量の添加(通常5重量%以上程度)を必要とするし
、又、それ以上は添加量を増しても効果は増加せず、顕
著な収れん効果を化粧料に付与するには至らない。Also, in Europe, it has been used as a decoction for gynecological diseases and as a sputum medicine since the Middle Ages. However, when the extract of Odoricum is added alone to cosmetics, its astringent effect is small, and even when trying to obtain a certain degree of astringent effect, a large amount (usually about 5% by weight or more) must be added. Moreover, even if the amount added is increased beyond this amount, the effect will not increase, and it will not be possible to impart a significant astringent effect to cosmetics.
本発明者等はかかる現状に鑑み、できるだけ少量の配
合でその効果を顕著に発揮させる観点から、オドリコ草
抽出物と特定の薬剤を組み合せて配合することによつて
、皮膚に対して安全で、しかも皮膚収れん剤としての十
分な効果を発揮させることができないかと考え、オドリ
コ草抽出物と各種薬剤との組合せについて系統的かつ厖
大な数の実験を繰返した結果、オドリコ草抽出物とビタ
ミンB6塩酸塩及び/又はL−アスコルビン酸とを組み
合せる場合には収れん効果を大幅に向上させることがで
きるという新知見を得、この知見を基として本発明を完
成したものである。In view of the current situation, the present inventors have developed a method that is safe for the skin and that is effective for the skin by combining and formulating a specific drug with an extract of Odoricum in order to exhibit its effect significantly with as little amount as possible. In addition, we thought that it would be possible to exert sufficient effects as a skin astringent, and as a result of systematically and repeatedly conducting a huge number of experiments on the combination of Nederopsis extract and various drugs, we found that Nederroum extract and vitamin B6 hydrochloric acid. We have obtained new knowledge that the astringent effect can be significantly improved when combined with salt and/or L-ascorbic acid, and based on this knowledge, we have completed the present invention.
すなわち、本発明はオドリコ草抽出物とビタミンB6塩
酸塩及び/又はL−アスコルビン酸とを配合することを
特徴とする皮膚収れん効果に優れた化粧料を提供するも
のである。That is, the present invention provides a cosmetic composition with an excellent skin astringent effect, which is characterized in that it contains an extract of sterilium extract and vitamin B6 hydrochloride and/or L-ascorbic acid.
本発明に用いられるオドリコ草抽出物は、オドリコ草の
茎、葉、花を1,3ブチレングリコール、プロピレング
リコール、エタノールなどの極性溶媒と水の混合抽出液
中で粉砕し、抽出物を溶液中に常温で抽出した後、濃縮
したもので有効成分としてポリフェノール、糖、アミノ
酸等を含有している。The extract used in the present invention is prepared by grinding the stems, leaves, and flowers of the sterilium in a mixed extract of water and a polar solvent such as 1,3 butylene glycol, propylene glycol, or ethanol, and then adding the extract to the solution. It is extracted at room temperature and then concentrated, and contains active ingredients such as polyphenols, sugars, and amino acids.
市販品としては、例えばフランスSOMCI−CHIM
IE社からEXTRAITD″0RTIEBLANC1
1Eという名で入手することができる。この抽出物を化
粧料に対して0.01重量%〜1鍾量%(好ましくは0
.2〜1重量%)を配合し、さらにビタミン八塩酸塩及
び/又はL−アスコルビン酸を配合する。オドリコ草抽
出物の配合量は、0.01重量%未満では効果がなく、
1鍾量%以上になると化粧料への着色が目立つようにな
るので好ましくない。本発明に用いられるビタミンB6
塩酸塩はビタミンB6の誘導体で、ビタミン八はヒト、
動物の.皮膚や血清中に存在し、欠乏すると脂漏性皮膚
炎、低色素性貧血、末梢神経炎等が起るとされている。As a commercially available product, for example, French SOMCI-CHIM
EXTRAITD″0RTIEBLANC1 from IE
It is available under the name 1E. This extract should be added in a range of 0.01% to 1% by weight (preferably 0% by weight) based on cosmetics.
.. 2 to 1% by weight), and further contains vitamin octahydrochloride and/or L-ascorbic acid. If the amount of Odoricum extract is less than 0.01% by weight, it will not be effective.
If the amount exceeds 1%, the coloring of the cosmetic will become noticeable, which is not preferable. Vitamin B6 used in the present invention
Hydrochloride is a derivative of vitamin B6, and vitamin 8 is a derivative of vitamin B6,
Animal's. It exists in the skin and serum, and its deficiency is said to cause seborrheic dermatitis, hypopigmentary anemia, peripheral neuritis, etc.
ビタミンB6塩酸塩の配合量はオドリコ草抽出物0.0
1〜1鍾量%を配合した化粧料に対して0.001〜1
重量%(好ましくは0.01〜0.鍾量%)!である。
0.001重量%未満では収れん効果向上の作用が少な
く、1重量%以上になると、光、温度による化粧料の着
色が顕著になるので好ましくない。The amount of vitamin B6 hydrochloride is 0.0 of the extract
0.001 to 1 for cosmetics containing 1 to 1%
Weight% (preferably 0.01 to 0.3%)! It is.
If it is less than 0.001% by weight, the effect of improving the astringent effect is small, and if it is more than 1% by weight, the coloring of the cosmetic due to light and temperature becomes noticeable, which is not preferable.
オドリコ草抽出物とビタミン八塩酸塩の比率は重量比で
1:100〜100:1(好ましくは5:1〜20:1
)である。1:100よりビタミンB6塩酸塩が多くな
ると、ビタミン八塩酸塩に起因する光、温度による化粧
料の着色が顕著になり、又、100:1よりビタミン八
塩酸塩が少なくなると、オドリコ草の収れん効果を向上
させる作用が十分に発揮されない。The weight ratio of Odoricum extract to vitamin octahydrochloride is 1:100 to 100:1 (preferably 5:1 to 20:1).
). When the amount of vitamin B6 hydrochloride increases from 1:100, the coloring of cosmetics due to light and temperature due to vitamin octahydrochloride becomes noticeable, and when the amount of vitamin octahydrochloride decreases from 100:1, the astringent The effect of improving the effect is not fully exerted.
本発明に用いられるL−アスコルビン酸はビタミンCと
して柑橘類、各種生野菜に含まれ、抗壊血作用を持つ。L-ascorbic acid used in the present invention is contained in citrus fruits and various raw vegetables as vitamin C, and has an antiscurvy effect.
また、還元力が強いため、メラニン生成抑制剤として使
われている。これをオドリコ草抽出物0.01〜1唾量
%を配合した化粧料に対し、0.001〜1重量%(好
ましくは0.05〜0.鍾量%)を配合する。0.00
1重量%未満では効果が少lなく、1重量%以上配合す
ると光、温度による化粧料への着色が目立つようになり
、好ましくない。It is also used as a melanin production inhibitor due to its strong reducing power. This is added in an amount of 0.001 to 1% by weight (preferably 0.05 to 0.00%) to a cosmetic containing 0.01 to 1% of the extract. 0.00
If it is less than 1% by weight, the effect will be poor, and if it is more than 1% by weight, the cosmetic will become noticeably colored by light and temperature, which is not preferable.
オドリコ草抽出物とL−アスコルビン酸の比率は重量比
で1:100〜100:1(好ましくは5:1〜20:
1)である。1:100よりアスコルビン酸が多くなる
とアスコルビン酸に起因する光、温度による化粧料への
着色が激しくなり、又、100:1よりアスコルビン酸
の配合量が少なくなると、オドリコ草の収れん効果を向
上させる作用が十分に発揮されない。The weight ratio of Odoricum extract to L-ascorbic acid is 1:100 to 100:1 (preferably 5:1 to 20:
1). When the amount of ascorbic acid increases from 1:100, the coloring of cosmetics due to light and temperature caused by ascorbic acid becomes intense, and when the amount of ascorbic acid blended decreases from 100:1, the astringent effect of doriko grass improves. The effect is not fully exerted.
なお、ビタミン八塩酸塩とL−アスコルビン酸とを併用
する場合には、両者を合計した量が、それぞれを単独で
用いた量と同じになるように調整すれば良い。Note that when vitamin octahydrochloride and L-ascorbic acid are used together, the total amount of both may be adjusted to be the same as the amount of each used alone.
それぞれ単独で用いたのと同程度の効果が得られる。本
発明に係る皮膚収れん化粧料にあつては、オドリコ草抽
出物の収れん効果をビタミンB6塩酸塩及び/又はL−
アスコルビン酸という薬剤の併用配合によつて飛躍的に
高め、肌のきめを整え、メークアップ化粧料の仕上りを
良くし、発汗等による化粧くすれを防ぎ、ひげ剃り後の
細かい切傷からの出血を抑える効果を備える一方、皮膚
に対して安全で、しかも光や温度に対しても安全で長期
の保管によつても着色等の劣化を起こしにくいので、非
常に有用な皮膚収れん化粧料ということができる。The same effect as using each alone can be obtained. In the skin astringent cosmetics according to the present invention, the astringent effect of Odoricum extract is combined with vitamin B6 hydrochloride and/or L-
The combination of a drug called ascorbic acid dramatically improves skin texture, improves the finish of makeup, prevents makeup from fading due to sweating, and reduces bleeding from small cuts after shaving. It is said to be a very useful skin astringent cosmetic because it has a suppressing effect, is safe for the skin, is also safe from light and temperature, and is resistant to deterioration such as discoloration even after long-term storage. can.
次に本発明者等が行つた数多くの実験例よりその一部を
抽出して本発明の構成、効果をより詳細に説明する。Next, the configuration and effects of the present invention will be explained in more detail by extracting some of the numerous experimental examples conducted by the present inventors.
実験例1
dオドリコ草抽出物(フランスSOMCI−CHIMI
E社製EXTRAITD″0RTIEBLANC1IE
)単独、eオドリコ草抽出物+ビタミン八塩酸塩0.1
重量%、fオドリコ草抽出物+L−アスコルビン酸0.
1重量%、iオドリコ草抽出物+ビタミン八塩酸塩0.
05重量%+アコルピン酸0.05重量%、gビタミン
B6塩酸塩単独、HL−アスコルビン酸単独をそれぞれ
95%エタノールの10重量%水溶液に溶解し、各々の
収れん作用をアルブミン水溶液による蛋白凝集力テスト
によつて比較した。Experimental Example 1
EXTRAITD″0RTIEBLANC1IE manufactured by E company
) Alone, e Odoricum extract + vitamin octahydrochloride 0.1
Weight %, f.
1% by weight, i. Odoricum extract + vitamin octahydrochloride 0.
05% by weight + 0.05% by weight of acorbic acid, g vitamin B6 hydrochloride alone, and HL-ascorbic acid alone were each dissolved in a 10% by weight aqueous solution of 95% ethanol, and the astringent effect of each was tested for protein cohesion with an albumin aqueous solution. Comparison was made by
アルブミン水溶液による蛋白凝集力テストは各種収斂剤
の収斂作用の測定のために、当業界や医薬品業界で一般
的に採用されているものである(フレグランス●ジャー
ナル?10\(1981)、川研ファインケミカル株式
会社製のパンフレツトRPCAアルミョ、昭和5岬12
月発行等)。The protein aggregation test using an aqueous albumin solution is commonly used in this industry and the pharmaceutical industry to measure the astringent action of various astringents (Fragrance ● Journal? 10 (1981), Kawaken Fine Chemical Co., Ltd. Pamphlet RPCA Armyo, Cape 12, Showa 5, manufactured by Co., Ltd.
Monthly issue, etc.)
(1)0.5重量%アルブミン水溶液を均一に攪拌溶解
し調整する。(2)オドリコ草抽出物を011、5、1
0重量%各々の容器に秤量し、これに組み合わせ薬剤を
0.1重量%加えたのち95%エタノールの1鍾量%水
溶液で10踵量部とする。(1) A 0.5% by weight albumin aqueous solution is uniformly stirred and dissolved. (2) Odoricum extract 011, 5, 1
0% by weight is weighed into each container, 0.1% by weight of the combined drug is added thereto, and the mixture is made up to 10 parts by weight with a 1% by weight aqueous solution of 95% ethanol.
(3) (1)の調整液1重量部と(2)の混合液4重
量部を試験管に秤量し混合する。(3) Weigh 1 part by weight of the adjustment solution in (1) and 4 parts by weight of the mixed solution in (2) in a test tube and mix.
(4)日本精密工学KK製積分球式濁度計で濁度を測定
(白板法)し、蛋白凝集力とする。(4) Measure the turbidity (white plate method) using an integrating sphere turbidity meter manufactured by Nippon Precision Engineering KK and use it as the protein cohesive force.
濁度が高い場合は収れん作用が強く、濁度が低い場合は
収れん作用が弱い。When the turbidity is high, the astringent effect is strong, and when the turbidity is low, the astringent effect is weak.
これらの測定結果を第1図に示す。なお第1図の横軸は
オドリコ草抽出物あるいはビタミンB6塩酸塩あるいは
L−アスコルビン酸の配合量(重量%)であり、縦軸は
実測した濁度値から、ブランク(95%エタノールの1
呼量%水溶液のみを混合したときの0.5重量%アルブ
ミン水溶液の濁度)を差引いた値である。第1図よりオ
ドリコ草単独での場合dよりもビタミン八塩酸塩を添加
した場合e1及びアスコルビン酸を添加した場合f1及
びビタミン八塩酸塩+L−アスコルビン酸を添加した場
合1の方がはるかに収れん作用が増大することがわかる
。The results of these measurements are shown in FIG. The horizontal axis in Figure 1 is the blended amount (wt%) of Odoricum extract, vitamin B6 hydrochloride, or L-ascorbic acid, and the vertical axis is the blank (95% ethanol 1%) based on the actually measured turbidity value.
This is the value obtained by subtracting the turbidity of a 0.5% by weight aqueous albumin solution when only the nominal volume % aqueous solution is mixed. From Figure 1, the astringency is much higher in e1 when vitamin octahydrochloride is added, in f1 when ascorbic acid is added, and in case 1 when vitamin octahydrochloride + L-ascorbic acid is added than in d, which is the case of only Odoricum grass. It can be seen that the effect increases.
実験例2次に本発明の皮膚化粧料について成人女性20
名を対象として塗布時の皮膚収れん効果及ひ塗布後の化
粧くすれの防止効果のテストを実施した。Experimental Example 2 Next, 20 adult women were asked about the skin cosmetics of the present invention.
We conducted tests on the skin astringent effect during application and the effect on preventing makeup from fading after application.
すなわち、下記コントロール用の通常のアストリンゼン
ト化粧水処方jにオドリコ草抽出物0.5重量%及びビ
タミンB6塩酸塩0.1重量%を含有させたアストリン
ゼント化粧水kと、jにオドリコ草0.5重量%及びL
−アスコルビン酸0.1重量%含有させたアストリンゼ
ント化粧水1をそれぞれ作成し、j<15kとを10名
のパネルに、又、jと1とを別の10名のパネルに1週
間、通常のメークアップ化粧料との併用で使用させ、そ
の結果を比較した。(製法)
(1)、(2)、(3)、(9)を常温で混合溶解する
。That is, an astringent lotion K containing 0.5% by weight of Adoricum extract and 0.1% by weight of vitamin B6 hydrochloride in the following normal astringent lotion formulation J for control, and 0.5 Astringent Lotion in j. Weight% and L
- Astringent lotion 1 containing 0.1% by weight of ascorbic acid was prepared, and j < 15k was given to a panel of 10 people, and j and 1 were given to another panel of 10 people for one week as usual. It was used in combination with makeup cosmetics and the results were compared. (Production method) Mix and dissolve (1), (2), (3), and (9) at room temperature.
これをやはり常温で混合溶解した(4)、(5)、(6
)、(7)、(8)中へ攪拌添加して透明な化粧水を得
る。オドリコ草抽出物、ビタミン八塩酸塩、L−アスコ
ルビン酸を配合するときは(5)、(6)、(7)、(
8)の水相中へあらかじめ溶解させておく。テスト結果
は第1表の如くであり、この結果から本発明の皮膚化粧
料が優れた収れん効果及びメークアップ等の化粧くずれ
防止に役立つことが立証された。This was also mixed and dissolved at room temperature (4), (5), (6)
), (7), and (8) to obtain a transparent lotion. (5), (6), (7), (
8) Dissolve in the aqueous phase in advance. The test results are shown in Table 1, and the results prove that the skin cosmetic of the present invention has an excellent astringent effect and is useful in preventing make-up from fading.
本発明の応用範囲としては、化粧水、プレシエープロー
シヨン、アフターシエープローシヨン、ヘアトニツク、
乳液、粉末入り化粧水等の水−アルコール系の化粧料が
考えられるが、いずれも肌をひきしめ、メークアップの
仕上り、化粧くずれ防止に有効である。The scope of application of the present invention includes lotions, pre-cheap lotions, after-cheap lotions, hair tonics,
Water-alcohol based cosmetics such as emulsions and powdered lotions can be considered, but all of them are effective in tightening the skin, improving the finish of makeup, and preventing makeup from fading.
またひげ剃り時の小さな切傷の止血効果にも優れている
。次に本発明の実施例をあげる。It also has an excellent hemostasis effect on small cuts when shaving. Next, examples of the present invention will be given.
実施例1
(収れん化粧水1)
(重量%)(
1)イオン交換水 81.82(2)
ジプロピレングリコール 2.0(3)クエン
酸 0.03(4)クエン
酸ソーダ 0.05(5)オドリコ
草抽出物 0.3(6)L−アスコルビ
ン酸 0.05(7)変性95%エタノー
ル 15.0(8)メチルバラペン
0.1(9)P.O.E.(15)オレイル
アルコールエーテル
0.5(10)香 料
0.1((1)紫外線防止剤 0.0
5(12)色素 適量(製 法)
(7)、(8)、(9)、(10を常温にて混合溶解し
、同じく常温で混合溶解した(1)、(2)、(3)、
(4)、(5)、(6)、(11)、(12)中へ攪拌
添加する。Example 1 (Astringent lotion 1) (wt%) (
1) Ion exchange water 81.82 (2)
Dipropylene glycol 2.0 (3) Citric acid 0.03 (4) Sodium citrate 0.05 (5) Odoricum extract 0.3 (6) L-Ascorbic acid 0.05 (7) Denatured 95% ethanol 15.0(8) Methylvarapen
0.1(9)P. O. E. (15) Oleyl alcohol ether
0.5 (10) fragrance
0.1 ((1) UV inhibitor 0.0
5 (12) Pigment Appropriate amount (manufacturing method) (7), (8), (9), (10 mixed and dissolved at room temperature, (1), (2), (3), also mixed and dissolved at room temperature,
Add to (4), (5), (6), (11), and (12) with stirring.
実施例2
(収れん化粧水2)
(重量%)(
1)イオン交換水 82.331(2
)ジプロピレングリコール 2.0(3)クエ
ン酸 0.03(4)クエ
ン酸ソーダ 0.05(5)オド
リコ草抽出物 0.3(6)ビタミン八
塩酸塩 0.05(7)L−アスコルビ
ン酸 0.05(8)変性95%エタノー
ル 15.0(9)P.O.E.(15)オ
レイルアルコールエーテル
0.05[相]香 料
0.1(11凛外線吸収剤
0.05(12)8素 適量(製 法)
(8)、(9)、AOを常温にて混合溶解し、同じく常
温にて混合溶解した(1)、(2)、(3)、(4)、
(5)、(6)、(7)、(11)、(12)中へ攪拌
添加する。Example 2 (Astringent lotion 2) (wt%) (
1) Ion exchange water 82.331 (2
) Dipropylene glycol 2.0 (3) Citric acid 0.03 (4) Sodium citrate 0.05 (5) Odoricum extract 0.3 (6) Vitamin octahydrochloride 0.05 (7) L-ascorbine Acid 0.05(8) Denatured 95% ethanol 15.0(9) P. O. E. (15) Oleyl alcohol ether
0.05 [phase] fragrance
0.1 (11 Rin external radiation absorber
0.05 (12) 8 elements Appropriate amount (manufacturing method) (8), (9), AO mixed and dissolved at room temperature, (1), (2), (3), (also mixed and dissolved at room temperature) 4),
Add to (5), (6), (7), (11), and (12) with stirring.
実施例3
(アフターシエープローシヨン)
(重量%)(
1)イオン交換水 57.75(2)
グリセリン 1.0(3)第一リ
ン酸ソーダ 0.1(4)クエン酸ソ
ーダ 0.1(5)アラントイン
0.05(6)オドリコ草抽出物
0.5(7)ビタミン八塩酸塩
0.2(8)変性95%エタノール
40.0(9)P.O.E.(60)硬化ヒマシ油付
加体0.5(10)紫外線吸収剤
0.05(11后料 0.1(12)色素
適量
(製 法)
(9)、(10、(11)を常温にて混合溶解し、同じ
く常温にて混合溶解した(1)、(2)、(3)(4)
、(5)、(6)、(7)、(8)、(12)中へ攪拌
添加する。Example 3 (Aftershave lotion) (wt%) (
1) Ion exchange water 57.75 (2)
Glycerin 1.0 (3) Monobasic sodium phosphate 0.1 (4) Sodium citrate 0.1 (5) Allantoin
0.05(6) Odoricum extract
0.5(7) Vitamin octahydrochloride
0.2(8) Denatured 95% ethanol
40.0(9)P. O. E. (60) Hydrogenated castor oil adduct 0.5 (10) Ultraviolet absorber
0.05 (after 11) 0.1 (12) dye
Appropriate amount (manufacturing method) (9), (10, (11)) were mixed and dissolved at room temperature, and (1), (2), (3) (4) were also mixed and dissolved at room temperature.
, (5), (6), (7), (8), and (12) with stirring.
実施例4(ヘアトニツク)
(重量%)(
1)イオン交換水 37.89(2)
PEG4OOl.O(3)ヒノキチオール
0.01(4)オドリコ草抽出物
1.0(5)ビタミン八塩酸塩 1.0
(6)変性95%エタノール 60.0(7
)POE硬化ヒマシ油付加体 0.5(8)e−
メントール 0.05(9)紫外線
吸収剤 0.1(10)香 料
0.1(11追素 適量
(製法)
(3)、(6)、(7)、(8)を常温にて混合溶解し
、同じく常温にて混合溶解した(1)、(2)、(4)
、(5)、(9)、[相]、(11)中に攪拌添加する
。Example 4 (hair tonic) (wt%) (
1) Ion exchange water 37.89 (2)
PEG4OOl. O(3) hinokitiol
0.01(4) Odoricum extract
1.0 (5) Vitamin octahydrochloride 1.0
(6) Denatured 95% ethanol 60.0 (7
) POE hydrogenated castor oil adduct 0.5(8)e-
Menthol 0.05 (9) Ultraviolet absorber 0.1 (10) Fragrance
0.1 (11 Additives Appropriate amount (manufacturing method) (3), (6), (7), (8) were mixed and dissolved at room temperature, and (1), (2), ( 4)
, (5), (9), [phase], and (11) with stirring.
実施例5
(アフターシエーブクリーム)
(重量%)(
1)イオン交換水 85.07(2)
PEG4OO2.O(3)グリセリン
3.0(4)アラントイン
0.05(5)オドリコ草抽出物 0
.2(6)ビタミン八塩酸塩 0.5(7
)流動パラフィン 4.0(8)ステア
リン酸 0.5(9)セタノール
2.0(10)POE(25)セ
チルアルコールエーテル
2.0(11)グリセリンモノステアレート
1.0(12)ブチルバラペン 0
.2(13)e−メントール 0.0
1(14播料 0.1(製 法)
(7)、(8)、(9)、(10)、(11)、(12
)、(13)、(14)を70℃にて混合溶解し、同じ
く70℃で混合溶解した(1)、(2)、(3)、(4
)、(5)、(6)中へ攪拌添加して乳化する。Example 5 (Aftershave cream) (wt%) (
1) Ion exchange water 85.07 (2)
PEG4OO2. O(3) glycerin
3.0(4) Allantoin
0.05(5) Odoricum extract 0
.. 2 (6) Vitamin octahydrochloride 0.5 (7
) Liquid paraffin 4.0 (8) Stearic acid 0.5 (9) Cetanol
2.0 (10) POE (25) Cetyl alcohol ether
2.0 (11) Glycerin monostearate 1.0 (12) Butylbarapen 0
.. 2(13)e-menthol 0.0
1 (14 sowing 0.1 (manufacturing method) (7), (8), (9), (10), (11), (12
), (13), and (14) were mixed and dissolved at 70°C, and (1), (2), (3), and (4) were also mixed and dissolved at 70°C.
), (5), and (6) with stirring to emulsify.
ホモジナイザーによつて乳化粒子を整え、その後、熱交
換器にて常温まで冷却する。実施例6
(粉末入り化粧水)
(重量%)
(1)イオン交換水 91.59(2
)グリセリン 1.0(3)オド
リコ草抽出物 0.2(4)L−アスコ
ルビン酸 0.05(5)変性95%エタ
ノール 5.0(6)亜鉛華
1.5(7)カオリン
0.5(8)e−メントール
0.01(9)メチルバラペン
0.05[相]香 料 0
.1(製 法)(1)、(2)、(3)、(4)を常温
にて混合溶解した後、ノ(6)、(7)をやはり常温に
て添加、攪拌して分散する。The emulsified particles are prepared using a homogenizer, and then cooled to room temperature using a heat exchanger. Example 6 (Powdered lotion) (wt%)
(1) Ion exchange water 91.59 (2
) Glycerin 1.0 (3) Odoricum extract 0.2 (4) L-ascorbic acid 0.05 (5) Denatured 95% ethanol 5.0 (6) Zinc white
1.5 (7) Kaolin
0.5(8)e-menthol
0.01(9) Methylvarapen
0.05 [Phase] Fragrance 0
.. 1 (Production method) After mixing and dissolving (1), (2), (3), and (4) at room temperature, (6) and (7) are added and stirred to disperse at room temperature.
これに、常温にて混合溶解した(5)、(8)、(9)
を攪拌添加する。(5), (8), (9) mixed and dissolved in this at room temperature
Stir and add.
第1図は実験例1における本発明及び比較例の蛋白凝集
力テストの結果である。
d・・・・・・オドリコ草抽出物、e・・・・・・オド
リコ草抽出物 ビタミン八塩酸塩0.1Wt%、f・・
・・・オドリコ草抽出物L−アスコルビン酸0.1Wt
%、g・・・・・・ビタミンB6塩酸塩、h・・・・・
・L−アスコルビン酸、i・・・・・オドリコ草抽出物
ビタミンB6塩酸塩0.1Wt%L−アスコルビン酸
0.1Wt%。FIG. 1 shows the results of a protein aggregation test of the present invention and a comparative example in Experimental Example 1. d...Odoriko grass extract, e...Odoriko grass extract vitamin octahydrochloride 0.1Wt%, f...
...Odoricum extract L-ascorbic acid 0.1Wt
%, g... Vitamin B6 hydrochloride, h...
-L-ascorbic acid, i...Odoricum extract Vitamin B6 hydrochloride 0.1wt% L-ascorbic acid 0.1wt%.
Claims (1)
L−アスコルビン酸とを配合したことを特徴とする化粧
料。1. A cosmetic product characterized by blending an extract of Odoricum and vitamin B6 hydrochloride and/or L-ascorbic acid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57063599A JPS6046083B2 (en) | 1982-04-16 | 1982-04-16 | cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57063599A JPS6046083B2 (en) | 1982-04-16 | 1982-04-16 | cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58180409A JPS58180409A (en) | 1983-10-21 |
| JPS6046083B2 true JPS6046083B2 (en) | 1985-10-14 |
Family
ID=13233896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57063599A Expired JPS6046083B2 (en) | 1982-04-16 | 1982-04-16 | cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6046083B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60188306A (en) * | 1984-03-07 | 1985-09-25 | Shiseido Co Ltd | Cosmetic |
| JPS60258104A (en) * | 1984-06-06 | 1985-12-20 | Inahata Koryo Kk | Cosmetic composition having moisture retention |
| ZA882036B (en) * | 1987-10-21 | 1989-11-29 | Warner Lambert Co | Lubricant for shaving |
-
1982
- 1982-04-16 JP JP57063599A patent/JPS6046083B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS58180409A (en) | 1983-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101922996B1 (en) | Hair dye with natural substance | |
| JPS6248611A (en) | External preparation for skin | |
| JPS63192705A (en) | External agent for skin | |
| KR20120057404A (en) | Cosmetic composition stabilized emulsification using natural inorganic thicker and anionic surfactant | |
| JPH0745421B2 (en) | Method for preventing discoloration of polyphenol | |
| JPH0545569B2 (en) | ||
| JPH0751491B2 (en) | Emulsified cosmetics containing crude drugs | |
| JPH1017435A (en) | Antioxidant composition | |
| JPS6046083B2 (en) | cosmetics | |
| JPS6155483B2 (en) | ||
| KR0154366B1 (en) | Liquid crystal gel for stabilized oil soluble extracts of glyoyrrhizae radix and cosmetic compositions containing the same | |
| JPH082819B2 (en) | Method for preventing discoloration of polyphenol | |
| JPH0745387B2 (en) | Hair growth and hair growth promoter | |
| JP2007269743A (en) | Topical skin preparation | |
| JPS6256411A (en) | Beautifying agent | |
| JPH1036282A (en) | Agent for suppressing breakage of mucopolysaccharide | |
| JP2602023B2 (en) | External preparation for skin | |
| JPH04169535A (en) | Composition for skin external preparation | |
| JPH0372202B2 (en) | ||
| JP2000212057A (en) | Cosmetic composition | |
| JPH08133950A (en) | Skin preparation for external use | |
| CN112603869A (en) | Whitening spot-lightening cream and preparation method thereof | |
| JPH0517202B2 (en) | ||
| JPH037212A (en) | Dermal preparation for external use | |
| JPH0582365B2 (en) |